Back to search

Article

Molecular Characterization of ERBB2-Altered Biliary Tract Cancer

2026-08-31

Abstract excerpt

<title>Abstract</title> <p>Purpose ERBB2-targeted therapies have demonstrated clinical activity in ERBB2-amplified biliary tract cancers (BTCs), highlighting the need to clarify molecular determinants of response. Methods We characterized the prevalence, anatomical distribution, and co-alteration patterns of ERBB2 amplifications and mutations using the AACR Project GENIE v19.0-public cohort. Activating ERBB2 al...

Identifiers and source

Literature Corpus work
33d17177-5e42-5abf-91dc-de3697318c38
DOI
10.21203/rs.3.rs-10682781/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular Characterization of ERBB2-Altered Biliary Tract CancerDOI 10.21203/rs.3.rs-10682781/v1
ERBB2 Pathway in Biliary Tract Carcinoma: Clinical Implications of a Targetable Pathway.Semantic proximity
Genomic Profiling of Biliary Tract Cancers: Comprehensive Assessment of Anatomic and Geographic Heterogeneity, Co‐Alterations and OutcomesSemantic proximity
Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors.Semantic proximity
Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targetsSemantic proximity
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.Semantic proximity
Biliary cancer: Utility of next-generation sequencing for clinical management.Semantic proximity
Genomic spectra of biliary tract cancer.Semantic proximity
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune SignaturesSemantic proximity
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors.Semantic proximity
Targeting ERBB2/HER2 genetic alterations: an expanding therapeutic opportunity in gastrointestinal cancers.Semantic proximity
The Epidemiology of Biliary Tract Cancer and Associated Prevalence of MDM2 Amplification: A Targeted Literature ReviewSemantic proximity
Genomic landscape and clinical characteristics of ERBB2/HER2-mutated colorectal cancers.Semantic proximity
Select a neighboring publication to make it the new centre.